Sarcopenia and obesity
4 findings
Associations
4ATP5F1B expression
downin silico1
1 study
ATP5F1B expression
downin silico1
Sarcopenia and obesity is associated with ATP5F1B expression in silico.
“were significantly downregulated in sarcopenia and obesity tissues, as validated by qPCR.”
In silicoSarcopenia skeletal muscle and obesity adipose tissue; expression validated by qPCRskeletal muscle and adipose tissue
Scientific reports6 Oct 2025
ATP5F1A expression
downin silico1
1 study
ATP5F1A expression
downin silico1
Sarcopenia and obesity is associated with ATP5F1A expression in silico.
“were significantly downregulated in sarcopenia and obesity tissues, as validated by qPCR.”
In silicoSarcopenia skeletal muscle and obesity adipose tissue; expression validated by qPCRskeletal muscle and adipose tissue
Scientific reports6 Oct 2025
SDHD expression
downin silico1
1 study
SDHD expression
downin silico1
Sarcopenia and obesity is associated with SDHD expression in silico.
“were significantly downregulated in sarcopenia and obesity tissues, as validated by qPCR.”
In silicoSarcopenia skeletal muscle and obesity adipose tissue; expression validated by qPCRskeletal muscle and adipose tissue
Scientific reports6 Oct 2025
SDHB expression
downin silico1
1 study
SDHB expression
downin silico1
Sarcopenia and obesity is associated with SDHB expression in silico.
“were significantly downregulated in sarcopenia and obesity tissues, as validated by qPCR.”
In silicoSarcopenia skeletal muscle and obesity adipose tissue; expression validated by qPCRskeletal muscle and adipose tissue
Scientific reports6 Oct 2025
Funding
1 grant since 2024National Institute on AgingUS$333.1k